APA
MacLeod D. L., Nelson L. E., Shawar R. M., Lin B. B., Lockwood L. G., Dirk J. E., Miller G. H., Burns J. L. & Garber R. L. (20000427). Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. : The Journal of infectious diseases.
Chicago
MacLeod D L, Nelson L E, Shawar R M, Lin B B, Lockwood L G, Dirk J E, Miller G H, Burns J L and Garber R L. 20000427. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. : The Journal of infectious diseases.
Harvard
MacLeod D. L., Nelson L. E., Shawar R. M., Lin B. B., Lockwood L. G., Dirk J. E., Miller G. H., Burns J. L. and Garber R. L. (20000427). Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. : The Journal of infectious diseases.
MLA
MacLeod D L, Nelson L E, Shawar R M, Lin B B, Lockwood L G, Dirk J E, Miller G H, Burns J L and Garber R L. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. : The Journal of infectious diseases. 20000427.